Hemo Organic Promoters Sell 16.38% Stake in Off-Market Deal

Promoters are offloading 5,67,958 shares representing 16.38% of existing equity capital.
The transaction was executed on September 22, 2026, via separate Share Purchase Agreements.

Reader Takeaway: Promoter stake reduces significantly, but buyers gain no special control or board representation rights in Hemo Organic.

What just happened

Promoters of Hemo Organic Limited, Mr. Dineshbhai Shanabhai Patel and Mrs. Sonalben Dineshbhai Patel, have transferred 5,67,958 equity shares to four separate entities in an off-market transaction. The buyers include Mrs. Ketanaben Jasani, Mrs. Heema Makadia, M/s. V9BIZ Business Solution LLP, and the Jasani Family Trust. Each of the first three buyers acquired 4.50% of the existing paid-up capital, while the Jasani Family Trust acquired 2.88%.

Why this matters

This transfer shifts a significant portion of the promoter's holding to external parties. While the company stated that no special rights—such as director appointment or veto powers—were granted to the new shareholders, investors often monitor such movements for potential long-term strategic shifts in company control or ownership concentration.

Terms and Conditions

Hemo Organic clarified that it was not a party to the Share Purchase Agreements and acted only in an informational capacity. The company explicitly stated that the transaction is not a related party deal and does not grant the new holders any pre-emptive rights or special governance authorities.

What to track next

Shareholders should look for upcoming disclosure updates regarding the updated shareholding pattern and any potential filing of changes in control or management influence, if any, that may emerge in subsequent quarterly disclosures.